A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Arbutamine
Decamethonium
The risk or severity of adverse effects can be increased when Decamethonium is combined with Flibanserin.
Arbutamine
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Flibanserin.
Arbutamine
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Flibanserin.
Arbutamine
Mivacurium
The risk or severity of adverse effects can be increased when Mivacurium is combined with Flibanserin.
Arbutamine
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Flibanserin.
Arbutamine
Dantrolene
The risk or severity of adverse effects can be increased when Dantrolene is combined with Flibanserin.
Arbutamine
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Flibanserin.
Arbutamine
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Flibanserin.
Arbutamine
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Flibanserin.
Arbutamine
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Flibanserin.
Arbutamine
Chlormezanone
The risk or severity of adverse effects can be increased when Chlormezanone is combined with Flibanserin.
Arbutamine
Cyclizine
The risk or severity of adverse effects can be increased when Cyclizine is combined with Flibanserin.
Arbutamine
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Flibanserin.
Arbutamine
Thiamylal
The risk or severity of adverse effects can be increased when Thiamylal is combined with Flibanserin.
Arbutamine
Doxacurium
The risk or severity of adverse effects can be increased when Doxacurium is combined with Flibanserin.
Arbutamine
Phenacemide
The risk or severity of adverse effects can be increased when Phenacemide is combined with Flibanserin.
Arbutamine
Methyprylon
The risk or severity of adverse effects can be increased when Methyprylon is combined with Flibanserin.
Arbutamine
Norethindrone enanthate
The risk or severity of adverse effects can be increased when Norethindrone enanthate is combined with Flibanserin.
Arbutamine
Nomegestrol acetate
The risk or severity of adverse effects can be increased when Nomegestrol acetate is combined with Flibanserin.
Arbutamine
Estradiol valerate
The risk or severity of adverse effects can be increased when Estradiol valerate is combined with Flibanserin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3